Peptides Similar to Humanin

Peptides Related to Humanin#

Humanin occupies a unique niche as the first identified mitochondrial-derived peptide with robust cytoprotective and anti-apoptotic properties. Unlike most neuroprotective peptides that act through neurotransmitter modulation or neurotrophic signaling, humanin directly inhibits the intrinsic apoptotic pathway and signals through a cytokine-type receptor complex. The following comparisons examine peptides with overlapping research applications.

Semax#

Semax is a synthetic ACTH(4-10) analog approved in Russia for cognitive enhancement and stroke recovery. While both humanin and semax are neuroprotective, their mechanisms differ fundamentally. Semax modulates BDNF expression and monoaminergic neurotransmission, whereas humanin blocks apoptotic cell death via Bax inhibition and gp130/STAT3 activation. Semax has the advantage of regulatory approval and extensive clinical use.

Pinealon#

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) with neuroprotective properties in preclinical models. Both peptides target neuronal survival, but humanin has substantially more mechanistic characterization and a defined receptor system. Pinealon's advantage lies in its small size and oral bioavailability.

Selank#

Selank is a synthetic tuftsin analog approved in Russia for anxiety and immune modulation. Both are neuroprotective but target different pathways. Selank primarily modulates GABAergic signaling and immune function, while humanin acts at the mitochondrial apoptotic machinery. Selank has clinical approval and a well-characterized safety profile.

DSIP#

DSIP (delta sleep-inducing peptide) is an endogenous neuropeptide primarily studied for sleep regulation. Both are naturally occurring peptides with cytoprotective properties, but their mechanisms and primary applications are entirely different.

Summary Comparison#

Comparison Context#

Humanin belongs to the Anti-Aging category of research peptides. Comparing Humanin with related compounds helps researchers understand its relative positioning in the therapeutic landscape. Each compound has distinct advantages and limitations that should be considered based on the specific research question or clinical need.

Detailed Comparisons#

The following peptides and compounds are most closely related to Humanin in mechanism, indication, or therapeutic category:

Humanin vs Semax#

Similarity: Moderate - Both are neuroprotective peptides with preclinical evidence for cognitive enhancement

Key Differences: Humanin is a mitochondrial-derived anti-apoptotic peptide acting via gp130/STAT3, while semax is a synthetic ACTH analog that modulates BDNF and neurotransmitter pathways. Semax is approved in Russia.

Advantages of Semax: Clinical approval in Russia, well-characterized nootropic effects, intranasal delivery, decades of clinical use

Disadvantages of Semax: Different mechanism (neurotransmitter modulation vs anti-apoptotic), no anti-aging or metabolic data comparable to humanin

Researchers choosing between Humanin and Semax should consider the development stage, available evidence, and specific research objectives when making their selection.

Humanin vs Pinealon#

Similarity: Low-Moderate - Both are neuroprotective peptides with anti-aging research applications

Key Differences: Humanin is a 24-amino acid mitochondrial-derived peptide while pinealon is a synthetic tripeptide that modulates gene expression in brain tissue. Different mechanisms and evidence bases.

Advantages of Pinealon: Very small size (tripeptide), oral bioavailability, simpler synthesis

Disadvantages of Pinealon: Much less preclinical evidence, no defined receptor, unclear mechanism of action

Researchers choosing between Humanin and Pinealon should consider the development stage, available evidence, and specific research objectives when making their selection.

Humanin vs Selank#

Similarity: Low-Moderate - Both are neuroprotective peptides studied for cognitive applications

Key Differences: Humanin targets mitochondrial apoptotic pathways while selank modulates anxiety and immune function via tuftsin analog activity. Selank is approved in Russia.

Advantages of Selank: Clinical approval, anxiolytic properties, immunomodulatory effects, well-characterized safety profile

Disadvantages of Selank: No direct anti-apoptotic or anti-aging mechanism, different target population and indications

Researchers choosing between Humanin and Selank should consider the development stage, available evidence, and specific research objectives when making their selection.

Humanin vs DSIP#

Similarity: Low - Both are endogenous neuropeptides with cytoprotective properties

Key Differences: Humanin is mitochondrial-derived and anti-apoptotic while DSIP is a hypothalamic peptide primarily studied for sleep regulation and stress response. Entirely different mechanisms.

Advantages of DSIP: Sleep-promoting effects, stress adaptation properties, longer research history

Disadvantages of DSIP: Less defined mechanism, no anti-aging data, no receptor clearly identified

Researchers choosing between Humanin and DSIP should consider the development stage, available evidence, and specific research objectives when making their selection.

Related Reading#

• Humanin overview and research guide
• Humanin research evidence
• Humanin dosing protocols